Bortezomib, a proteasome inhibitor, synergizes with DFMO to inhibit neuroblastoma cell proliferation via the reversal of the LIN28/Let-7 axis

Rich M, Zhao P, Nagulapally AB, Bond J, Saulnier Sholler G,  Bortezomib, a proteasome inhibitor, synergizes with DFMO to inhibit neuroblastoma cell proliferation via the reversal of the LIN28/Let-7 axis. American Association of Cancer Research (AACR) Annual Meeting, 2015.  Philadelphia, PA